Skip to content

Longevity Drug Index / Senolytics

Rank 6 of 10Unproven

Senolytics

Drugs designed to clear out worn-out, inflammatory cells that build up with age.

Rank
6 of 10
Drug class
Drugs that clear senescent cells
Approved for
None for this use
Also known as
Dasatinib plus quercetin, fisetin

How it works

Senescent cells have stopped dividing but refuse to die. They release a mix of inflammatory signals that damages nearby tissue. To survive, they rely on protective pathways such as the BCL-2 family. Senolytics briefly switch off these pathways, so senescent cells die while healthy cells are largely spared. They are usually given in short bursts rather than every day.

How it could help longevity

Senescent cells accumulate with age and are found in damaged joints, lungs, fat, blood vessels and the brain. Clearing them could reduce chronic inflammation and help tissues work better, potentially tackling several age-related diseases at once.

Animal studies

  • Genetic clearance, 2016Mice engineered so their senescent cells could be destroyed on demand lived about 25% longer, with healthier kidneys and hearts.
  • Dasatinib plus quercetin, 2018Given to very old mice, the combination improved physical function and extended their remaining lifespan by about 36%.
  • Fisetin, 2018This natural compound reduced senescent cells and extended lifespan in aged mice.
  • CaveatMost positive results come from old, sick or damaged animals rather than healthy ones.

Human studies

  • Lung fibrosis pilot, 2019In 14 people with idiopathic pulmonary fibrosis, three weeks of dasatinib plus quercetin improved walking distance and speed. The study had no placebo group.
  • Bone trial in older women, 2024A randomised trial found no overall effect on bone formation, though women with the most senescent cells showed some benefit.
  • OverallHuman trials so far are small, short and mixed. Several larger trials are under way.

Safety and side effects

Dasatinib is a leukaemia drug that can lower blood counts, cause fluid build-up and increase bleeding risk. Navitoclax, another senolytic, sharply lowers platelets. Senescent cells also play useful roles in wound healing, so long-term effects of clearing them are unknown. Fisetin and quercetin are sold as supplements, but doses and purity vary.

Our view

An exciting idea with impressive results in old mice, but little solid evidence in people. Not ready for routine use outside trials.

Last reviewed 11 November 2026. General information, not medical advice. None of these drugs is approved to slow aging.